Mitochondria play a critical role in cardioprotection

Journal of Cardiac Failure

Volumn 10, Issue 1, 2004, Pages 55-66

  Marín García, José ^a   Goldenthal, Michael J ^a  

^a Molec Cardiol/Neuromuscular Inst   (United States)

Author keywords

free radicals; K ATP channels; Mitochondria; preconditioning; signal transduction

Indexed keywords

ANTIOXIDANT; MITOCHONDRIAL PROTEIN;

BIOENERGY; CELL FUNCTION; DRUG DESIGN; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; LIVER MITOCHONDRION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MODEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 3042732496     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(03)00129-5     Document Type: Article

References (133)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 74:1986;1124-1136
2. Lesnefsky E.J., Slabe T.J., Stoll M.S., Minkler P.E., Hoppel C.L. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol. 280:2001;H2770-H2778
3. O'Rourke B. Myocardial KATP channels in preconditioning. Circ Res. 87:2000;845-855
4. Szewczyk A., Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev. 54:2002;101-127
5. Garlid K.D., Paucek P., Yarov-Yarovoy V., Murray H.N., Darbenzio R., D'Alonzo A.J., et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res. 81:1997;1072-1082
6. D'hahan N., Moreau C., Prost A.L., Jacquet H., Alekseev A.E., Terzic A., et al. Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci USA. 96:1999;12162-12167
7. Sanada S., Kitakaze M., Asanuma H., Harada K., Ogita H., Node K., et al. Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart. Am J Physiol Heart Circ Physiol. 280:2001;H256-H263
8. Xu W., Liu Y., Wang S., McDonald T., Van Eyk J.E., Sidor A., et al. Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane. Science. 298:2002;1029-1033
9. Paucek P., Mironova G., Mahdi F., Beavis A.D., Woldegiorgis G., Garlid K.D. Reconstitution and partial purification of the glibenclamide-sensitive, ATP-dependent K+ channel from rat liver and beef heart mitochondria. J Biol Chem. 267:1992;26062-26069
10. Bajgar R., Seetharaman S., Kowaltowski A.J., Garlid K.D., Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem. 276:2001;33369-33374
11. Babenko A.P., Gonzalez G., Aguilar-Bryan L., Bryan J. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ Res. 83:1998;1132-1143
12. Seharaseyon J., Ohler A., Sasaki N., Fraser H., Sato T., Johns D.C., et al. Molecular composition of mitochondrial ATP-sensitive potassium channels probed by viral Kir gene transfer. J Mol Cell Cardiol. 32:2000;1923-1930
13. Korge P., Honda H.M., Weiss J.N. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci USA. 99:2002;3312-3317
14. Murata M., Akao M., O'Rourke B., Marban E. Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res. 89:2001;891-898
15. Holmuhamedov E.L., Wang L., Terzic A. ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol. 519:1999;347-360
16. Katoh H., Nishigaki N., Hayashi H. Diazoxide opens the mitochondrial permeability transition pore and alters Ca2+ transients in rat ventricular myocytes. Circulation. 105:2002;2666-2671
17. Xu M., Wang Y., Ayub A., Ashraf M. Mitochondrial K(ATP) channel activation reduces anoxic injury by restoring mitochondrial membrane potential. Am J Physiol Heart Circ Physiol. 281:2001;H1295-H1303
18. Griffiths E.J., Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J. 307:1995;93-98
19. Crompton M., Costi A. Kinetic evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. A potential mechanism for mitochondrial dysfunction during cellular Ca2+ overload. Eur J Biochem. 178:1988;489-501
20. Minners J., van den Bos E.J., Yellon D.M., Schwalb H., Opie L.H., Sack M.N. Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res. 47:2000;68-73
21. Zhao Z.Q., Nakamura M., Wang N.P., Wilcox J.N., Shearer S., Ronson R.S., et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res. 45:2000;651-660
22. Zhao Z.Q., Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res. 55:2002;438-455
23. Opie L.H., Sack M.N. Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning. J Mol Cell Cardiol. 34:2002;1077-1089
24. Knopp A., Thierfelder S., Doepner B., Benndorf K. Mitochondria are the main ATP source for a cytosolic pool controlling the activity of ATP-sensitive K(+) channels in mouse cardiac myocytes. Cardiovasc Res. 52:2001;236-245
25. Trochu J.N., Bouhour J.B., Kaley G., Hintze T.H. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease. Circ Res. 87:2000;1108-1117
26. Miura T., Liu Y., Kita H., Ogawa T., Shimamoto K. Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation. J Am Coll Cardiol. 35:2000;238-245
27. Kobara M., Tasumi T., Matoba S., Yamahara Y., Nakagawa C., Ohta B., et al. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts. J Mol Cell Cardiol. 28:1997;417-428
28. Wang Y., Hirai K., Ashraf M. Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res. 85:1999;731-741
29. Bosetti F., Yu G., Zucchi R., Ronca-Testoni S., Solaini G. Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity. Mol Cell Biochem. 215:2000;31-37
30. Vuorinen K., Ylitalo K., Peuhkurinen K., Raatikainen P., Ala-Rami A., Hassinen I.E. Mechanisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase. Circulation. 91:1995;2810-2818
31. Ozcan C., Holmuhamedov E.L., Jahangir A., Terzic A. Diazoxide protects mitochondria from anoxic injury: implications for myopreservation. J Thorac Cardiovasc Surg. 121:2001;298-306
32. Green D.W., Murray H.N., Sleph P.G., Wang F.L., Baird A.J., Rogers W.L., Grover G.J. Preconditioning in rat hearts is independent of mitochondrial F1F0 ATPase inhibition. Am J Physiol. 274:1998;H90-H97
33. Asimakis G.K., Inners-McBride K., Medellin G., Conti V.R. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol. 263:1992;H887-H894
34. Laclau M.N., Boudina S., Thambo J.B., Tariosse L., Gouverneur G., Bonoron-Adele S., et al. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol. 33:2001;947-956
35. Da Silva M.M., Sartori A., Belisle E., Kowaltowski A.J. Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release and enhances K+ transport. Am J Physiol Heart Circ Physiol. 285:2003;H154-H162
36. Garlid K.D. Opening mitochondrial K(ATP) in the heart - what happens, and what does not happen. Basic Res Cardiol. 95:2000;275-279
37. Halestrap A.P. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta. 23:(973):1989;355-382
38. Halestrap A.P. Regulation of mitochondrial metabolism through changes in matrix volume. Biochem Soc Trans. 22:1994;522-529
39. Dos Santos P., Kowaltowski A.J., Laclau M.N., Seetharaman S., Paucek P., Boudina S., et al. Mechanisms by which opening the mitochondrial ATP- sensitive K(+) channel protects the ischemic heart. Am J Physiol Heart Circ Physiol. 283:2002;H284-H295
40. Oldenburg O., Cohen M., Yellon D., Downey J. Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc Res. 55:2002;429-437
41. Mubagwa K., Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res. 52:2001;25-39
42. Liu G.S., Thornton J., Van Winkle D.M., Stanley A.W., Olsson R.A., Downey J.M. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356
43. Cohen M.V., Baines C.P., Downey J.M. Ischemic preconditioning: from adenosine receptor of KATP channel. Annu Rev Physiol. 62:2000;79-109
44. Qin Q., Downey J.M., Cohen M.V. Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am J Physiol Heart Circ Physiol. 284:2003;H727-H734
45. Lecour S., Smith R.M., Woodward B., Opie L.H., Rochette L., Sack M.N. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol. 34:2002;509-518
46. Wang Y., Hirai K., Ashraf M. Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res. 85:1999;731-741
47. Wang Y., Ashraf M. Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium. Circ Res. 84:1999;1156-1165
48. Ping P., Song C., Zhang J., Guo Y., Cao X., Li R.C., et al. Formation of protein kinase C (epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest. 109:2002;499-507
49. Baines C.P., Zhang J., Wang G.W., Zheng Y.T., Xiu J.X., Cardwell E.M., et al. Mitochondrial PKCepsilon and MAPK form signaling modules interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res. 90:2002;390-397
50. Dorn G.W. 2nd, Souroujon M.C., Liron T., Chen C.H., Gray M.O., Zhou H.Z., et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci USA. 96:1999;12798-12803
51. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon, PKC. Proc Natl Acad Sci USA. 98:2001;11114-11119
52. Zhao T.C., Hines D.S., Kukreja R.C. Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol. 280:2001;H1278-H1285
53. Fryer R.M., Schultz J.E., Hsu A.K., Gross G.J. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol Heart Circ Physiol. 276:1999;H1229-H1235
54. Schulz R., Cohen M.V., Behrends M., Downey J.M., Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res. 52:2001;181-198
55. Kulisz A., Chen N., Chandel N.S., Shao Z., Schumacker P.T. Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am J Physiol Lung Cell Mol Physiol. 282:2002;L1324-L1329
56. Das D.K., Maulik N., Sato M., Ray P.S. Reactive oxygen species function as second messenger during ischemic preconditioning of heart. Mol Cell Biochem. 196:1999;59-67
57. Gudz T., Tserng K., Hoppel C.L. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J Biol Chem. 272:1997;24154-24158
58. Krenz M., Oldenburg O., Wimpee H., Cohen M.V., Garlid K.D., Critz S.D., et al. Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol. 97:2002;365-373
59. Pain T., Yang X.M., Critz S.D., Yue Y., Nakano A., Liu G.S., et al. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res. 87:2000;460-466
60. Cohen M.V., Yang X.M., Liu G.S., Heusch G., Downey J.M. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res. 89:2001;273-278
61. Halmosi R., Berente Z., Osz E., Toth K., Literati-Nagy P., Sumegi B. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion- induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Mol Pharmacol. 59:2001;1497-1505
62. Van den Hoek T.L., Becker L.B., Shao Z., Li C., Schumacker P.T. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem. 273:1998;18092-18098
63. Ozcan C., Bienengraeber M., Dzeja P.P., Terzic A. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol. 282:2002;H531-H539
64. Hausenloy D.J., Maddock H.L., Baxter G.F., Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res. 55:2002;534-543
65. Yue Y., Qin Q., Cohen M.V., Downey J.M., Critz S.D. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res. 55:2002;681-689
66. Ping P., Murphy E. Role of p38 mitogen-activated protein kinases in preconditioning: a detrimental factor or a protective kinase? Circ Res. 86:2000;921-922
67. Hanley P.J., Mickel M., Loffler M., Brandt U., Daut J. K(ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol. 542:2002;735-741
68. Lim K.H., Javadov S.A., Das M., Clarke S.J., Suleiman M.S., Halestrap A.P. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol. 545:2002;961-974
69. Grimmsmann T., Rustenbeck I. Direct effects of diazoxide on mitochondria in pancreatic B-cells and isolated liver mitochondria. Br J Pharmacol. 123:1998;781-788
70. Akao M., O'Rourke B., Kusuoka H., Teshima Y., Jones S.P., Marban E. Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ Res. 92:2003;195-202
71. Zaugg M., Lucchinetti E., Spahn D.R., Pasch T., Garcia C., Schaub M.C. Differential effects of anesthetics on mitochondrial K(ATP) channel activity and cardiomyocyte protection. Anesthesiology. 97:2002;15-23
72. Hanley P.J., Ray J., Brandt U., Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol. 544:2002;687-693
73. Bolli R. The late phase of preconditioning. Circ Res. 87:2000;972-983
74. Strohm C., Barancik M., von Bruehl M., Strniskova M., Ullmann C., Zimmermann R., et al. Transcription inhibitor actinomycin-D abolishes the cardioprotective effect of ischemic reconditioning. Cardiovasc Res. 55:2002;602-618
75. Zhao T.C., Kukreja R.C. Late preconditioning elicited by activation of adenosine A (3) receptor in heart: role of NF-kappa B, iNOS and mitochondrial K(ATP) channel. Mol Cell Cardiol. 34:2002;263-277
76. Hoshida S., Yamashita N., Otsu K., Hori M. The importance of manganese superoxide dismutase in delayed preconditioning. Involvement of reactive oxygen species and cytokines. Cardiovasc Res. 55:2002;495
77. Wang Y., Kudo M., Xu M., Ayub A., Ashraf M. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide. Mol Cell Cardiol. 33:2001;2037-2046
78. Ockaili R., Emani V.R., Okubo S., Brown M., Krottapalli K., Kukreja R.C. Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am J Physiol. 277:1999;H2425-H2434
79. Pagliaro P., Gattullo D., Rastaldo R., Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sci. 69:2001;1-15
80. Latchman D.S. Heat shock proteins and cardiac protection. Cardiovasc Res. 51:2001;637-646
81. Lebuffe G., Schumacker P.T., Shao Z.H., Anderson T., Iwase H., Vanden Hoek T.L. Reactive oxygen and nitrogen species trigger early preconditioning: relationship to the mitochondrial KATP channel. Am J Physiol Heart Circ Physiol. 284:2003;H299-H308. Epub 2002 Sep 26
82. Rakhit R.D., Mojet M.H., Marber M.S., Duchen M.R. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation. 103:2001;2617-2623
83. Yamashita N., Hoshida S., Otsu K., Taniguchi N., Kuzuya T., Hori M. The involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol. 131:2000;415-422
84. Gille L., Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med. 23:1997;775-782
85. Adachi K., Fujiura Y., Mayumi F., Nozuhara A., Sugiu Y., Sakanashi T., et al. A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. Biochem Biophys Res Commun. 195:1993;945-951
86. Palmeira C.M., Serrano J., Kuehl D.W., Wallace K.B. Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin. Biochim Biophys Acta. 1321:1997;101-106
87. Solem L.E., Henry T.R., Wallace K.B. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol Appl Pharmacol. 129:1994;214-222
88. Abdel-aleem S., el-Merzabani M.M., Sayed-Ahmed M., Taylor D.A., Lowe J.E. Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes. J Mol Cell Cardiol. 29:1997;789-797
89. Jeyaseelan R., Poizat C., Wu H.Y., Kedes L. Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes. J Biol Chem. 272:1997;5828-5832
90. Zhou S., Starkov A., Froberg M.K., Leino R.L., Wallace K.B. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res. 61:2001;771-777
91. Delpy E., Hatem S.N., Andrieu N., de Vaumas C., Henaff M., Rucker-Martin C., et al. Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes. Cardiovasc Res. 43:1999;398-407
92. Ito H., Shimojo T., Fujisaki H., Tamamori M., Ishiyama S., Adachi S., et al. Thermal preconditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis. Life Sci. 64:1999;755-761
93. Kumar D., Kirshenbaum L.A., Li T., Danelisen I., Singal P.K. Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal. 3:2001;135-145
94. Nakamura T., Ueda Y., Juan Y., Katsuda S., Takahashi H., Koh E. Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: in vivo study. Circulation. 102:2000;572-578
95. Wang G.W., Klein J.B., Kang Y.J. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther. 298:2001;461-468
96. Yen H.C., Oberley T.D., Gairola C.G., Szweda L.I., St Clair D.K. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch Biochem Biophys. 362:1999;59-66
97. Shneyvays V., Mamedova L., Zinman T., Jacobson K., Shainberg A. Activation of A (3) adenosine receptor protects against doxorubicin-induced cardiotoxicity. J Mol Cell Cardiol. 33:2001;1249-1261
98. Konorev E.A., Kennedy M.C., Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates. Arch Biochem Biophys. 368:1999;421-428
99. Dorr R.T. Cytoprotective agents for anthracyclines. Semin Oncol. 23:1996;23-34
100. McCully J.D., Lotz M.M., Krukenkamp I.B., Levitsky S. A brief period of retrograde hyperthermic perfusion enhances myocardial protection from global ischemia: association with accumulation of Hsp 70 mRNA and protein. J Mol Cell Cardiol. 28:1996;231-241
101. Jayakumar J., Suzuki K., Sammut I.A., Smolenski R.T., Khan M., Latif N., et al. Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation. 104:2001;I303-I307
102. Altura B.M., Zou L.Y., Altura B.T., Jelicks L., Wittenberg B.A., Gupta R.K. Beneficial vs. detrimental actions of ethanol on heart and coronary vascular muscle: roles of Mg2+ and Ca2+. Alcohol. 13:1996;499-513
103. Zhou H.Z., Karliner J.S., Gray M.O. Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. Am J Physiol Heart Circ Physiol. 283:2002;H165-H174
104. Chen C., Mochly-Rosen D. Opposing effects of delta and xi PKC in ethanol-induced cardioprotection. J Mol Cell Cardiol. 33:2001;581-585
105. Pagel P.S., Toller W.G., Gross E., Gare M., Kersten J.R., Warltier D.C. KATP channels mediate the beneficial effects of chronic ethanol ingestion. Am J Physiol Heart Circ Physiol. 279:2000;H2574-H2579
106. Zhu P., Zhou H.Z., Gray M.O. Chronic ethanol-induced myocardial protection requires activation of mitochondrial K(ATP) channels. J Mol Cell Cardiol. 32:2000;2091-2095
107. Miyamae M., Diamond I., Weiner M.W., Camacho S.A., Figueredo V.M. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci USA. 94:1997;3235-3239
108. Miyamae M., Rodriguez M.M., Camacho S.A., Diamond I., Mochly-Rosen D., Figueredo V.M. Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci U S A. 95:1998;8262-8267
109. Miyamae M., Camacho S.A., Zhou H.Z., Diamond I., Figueredo V.M. Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats. Am J Physiol. 275:1998;H50-H56
110. Krenz M., Baines C.P., Heusch G., Downey J.M., Cohen M.V. Acute alcohol-induced protection against infarction in rabbit hearts: differences from and similarities to ischemic preconditioning. J Mol Cell Cardiol. 33:2001;2015-2022
111. Krenz M., Cohen M.V., Downey J.M. The protective and anti-protective effects of ethanol in a myocardial infarct model. Ann N Y Acad Sci. 957:2002;103-114
112. Tani M., Honma Y., Hasegawa H., Tamaki K. Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res. 49:2001;56-68
113. Takayama M., Ebihara Y., Tani M. Differences in the expression of protein kinase C isoforms and its translocation after stimulation with phorbol ester between young-adult and middle-aged ventricular cardiomyocytes isolated from Fischer 344 rats. Jpn Circ J. 65:2001;1071-1076
114. Locke M., Tanguay R.M. Diminished heat shock response in the aged myocardium. Cell Stress Chaperones. 1:1996;251-260
115. Honma Y., Tani M., Takayama M., Yamamura K., Hasegawa H. Aging abolishes the cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts. Basic Res Cardiol. 97:2002;489-495
116. Tani M., Suganuma Y., Hasegawa H., Shinmura K., Ebihara Y., Hayashi Y., et al. Decrease in ischemic tolerance with aging in isolated perfused Fischer 344 rat hearts: relation to increases in intracellular Na+ after ischemia. J Mol Cell Cardiol. 29:1997;3081-3089
117. Lopez Jimenez J.A., Bordoni A., Lorenzini A., Rossi C.A., Biagi P.L., Hrelia S. Linoleic acid metabolism in primary cultures of adult rat cardiomyocytes is impaired by aging. Biochem Biophys Res Commun. 237:1997;142-145
118. Awad A.B., Clay S.W. Age-dependent alterations in lipids and function of rat heart sarcolemma. Mech Ageing Dev. 19:1982;333-342
119. Pepe S. Mitochondrial function in ischaemia and reperfusion of the ageing heart. Clin Exp Pharmacol Physiol. 27:2000;745-750
120. Paradies G., Ruggiero F.M. Age-related changes in the activity of the pyruvate carrier and in the lipid composition in rat-heart mitochondria. Biochim Biophys Acta. 1016:1990;207-221
121. Marin-Garcia J., Ananthakrishnan R., Goldenthal M.J. Human mitochondrial function during cardiac growth and development. Mol Cell Biochem. 179:1998;21-26
122. Miro O., Casademont J., Casals E., Perea M., Urbano-Marquez A., Rustin P., et al. Aging is associated with increased lipid peroxidation in human hearts, but not with mitochondrial respiratory chain enzyme defects. Cardiovasc Res. 47:2000;624-631
123. Muller-Hocker J. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart - an age-related phenomenon. A histochemical ultracytochemical study. Am J Pathol. 134:1989;1167-1173
124. Wanagat J., Wolff M.R., Aiken J.M. Age-associated changes in function, structure and mitochondrial genetic and enzymatic abnormalities in the Fischer 344 x Brown Norway F(1) hybrid rat heart. J Mol Cell Cardiol. 34:2002;17-28
125. Lesnefsky E.J., Gudz T.I., Moghaddas S., Migita C.T., Ikeda-Saito M., Turkaly P.J., et al. Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol. 33:2001;37-47
126. Muscari C., Giaccari A., Stefanelli C., Viticchi C., Giordano E., Guarnieri C., et al. Presence of a DNA-4236 bp deletion and 8-hydroxy- deoxyguanosine in mouse cardiac mitochondrial DNA during aging. Aging. 8:1996;429-433
127. Cortopassi G.A., Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 18:1990;6927-6933
128. Marin-Garcia J., Goldenthal M.J. Understanding the impact of mitochondrial defects in cardiovascular disease: a review. J Card Fail. 8:2002;347-361
129. Marin-Garcia J., Goldenthal M.J., Ananthakrishnan R., Pierpont M.E., Fricker F.J., Lipshultz S.E., et al. Specific mtDNA deletions in idiopathic dilated cardiomyopathy. Cardiovasc Res. 31:1996;306-313
130. Hayakawa M., Sugiyama S., Hattori K., Takasawa M., Ozawa T. Age-associated damage in mitochondrial DNA in human hearts. Mol Cell Biochem. 119:1993;95-103
131. Ferdinandy P., Szilvassy Z., Baxter G.F. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci. 19:1998;223-229
132. Ghosh S., Standen N.B., Galinianes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol. 37:2001;711-718
133. Kloner R., Speakman M., Przyklenk K. Ischemic preconditioning: a plea for rationally targeted clinical trials. Cardiovasc Res. 55:2002;526-533